|
Minutes from the MASCC/ISOO General Assembly
Geneva, Switzerland
June 30, 2005
 SEE BELOW for Study Group Minutes
Dr. Matti Aapro, President, called to order the MASCC/ISOO General Assembly Thursday, July 1, 2005 in Geneva Switzerland in the Crowne Plaza Hotel at 12:10. He welcomed those attending and thanked the Scientific Committee, MASCC Executive Committee, the Executive Director, meeting planner (Debbie Kurth), Tatjana Romanyk, the Board, sponsors, and all others involved.
Minutes of the previous General Assembly were approved.
M Aapro announced the appointment of Dr. Judi Johnson as Associate Director, MASCC and stated she would be responsible for study groups, the web site, and the professional liaison committee.
C Rittenberg gave an executive director report.
Committee chairs reports:
Nominating – D Peterson reported that 11 members of the Board of Directors would be elected in Spring 2006, with installation at the Symposium of 2006.
Professional Liaison – D Peterson reported the goal of the committee was to establish relationships with like organizations.
Governance – While, quiet the last 6 months, M Aapro announced that the Governance Committee would be reviewing old and new issues in the next several months.
Development – P Hesketh reported the goal of the committee to date has been to increase MASCC exposure; this has been accomplished via such things as collaboration with Oncology Special Edition, Touch Briefings, Cancer Care, etc. He mentioned the development of an industrial contact data-base; the idea of an ad concept; and perhaps a Foundation.
ISOO report – Dr. Judith Raber-Durlacher, President, thanked the MASCC Board, President Aapro, and ED Cindy Rittenberg for the collaborative relationship. She stated that MASCC/ISOO was a unique alliance. D Peterson addition the accomplishments of the past year:
Administrative
1. Completed elections.
2. Renewal of Memo of Understanding with MASCC.
3. Formulation of new model for the ISOO liaison to MASCC. ISOO will choose the member to be on the board. This person can serve up to three two-year terms.
4. Initiated review of the By-laws and Articles of Incorporation of ISOO.
Scientific
1. Collaboration with the mucositis study group in the updating of mucositis guidelines.
2. Oral care study group formulated a project re oral complications of cancer treatment.
3. Implementation of a CE course during the Geneva meeting aimed at area dentists and those interested in dental care. This will take place tomorrow afternoon.
4. Discussing the formation a new International Academy of Oral Oncology. Those who formed it historically were interested or oral carcinogen sis and head and neck cancers with little focus on supportive care.
He also announced the ISOO CE course would take place this afternoon.
Study Group reports – deferred
International Meeting
Geneva – About 600 are registered
Toronto – June 22-25 – Sheraton Centre – Ron Feld chair and Andrea Bezjak co-chair
St. Gallen – June 27-30. 20th Anniversary. OLMA Center. HJ Senn and A Glaus, co – chairs.
Web site
RJ Gralla discussed updates, Research and Education Centers, literature review. Thanked Beth Hollen, managing editor.
Young Investigators announced and certificates distributed:
Supported by:
GlaxoSmithKline and Merck & Co., Inc.
Young Investigator of the Year
Sultan Kav, RN, PhD – Turkey
Young Investigator Awards
Ozlem Aslan – Turkey
Elenir Avritscher, MD – United States
Leandro Cerchietti, MD – Argentina
Christopher Friese, RN, PhD – United States
Katie Inglis, BHSc (Sci Hons) Australia
Nicole Kuderer, MD – United States
Sergejs Kuznecovs, MD – Latvia
Rajesh Lalla, BDS, PhD – United States
Ann Yeoh, BmedSc (Hons) – Australia
Travel Awards announced:
Travel Scholarship Recipients - 2005
Supported by: Amgen AG, Amgen, Inc., Lance Armstrong Foundation,
and Merck & Co., Inc.
Ahmad Al-Khatib, RN – Jordan
Anura Ariyawardana, DDS – Sri-Lanka
Natalia Bodiu, MD – Moldova
Humeyra Bostanci, RN – Turkey
Ivana Bozovic Spasooevic, MD – Serbia
Eugeny Demin, MD – Russia
Fernando Diaz Couselo – Argentina
Fathelrahman Hassan, MD – Sudan
Oleksandr Ivashchuk, MD – Ukraine
Galina Kuznecova, RN – Latvia
Haykanush Kzhdryan, MD – Armenia
David Makumi Kinyanjui, RN – Kenya
Ali Montazeri, MD – Iran
Katalin Nagy, DDS – Hungary
K. Pavithran, MD – India
Margaret Pesala, RN – India
B. Nageswara Rao, MD – India
Suresh Sanchetee, MD – India
Camelia-Aneta Sandu, MD – Romaina
Audrone Savinyte, RN – Lithuania
Sureepom Thanasilp, RN – Thailand
Boris Zaidiner, MD – Russia
Best Posters Announced - 2005
A Prospective Investigation of Chemotherapy Induced Neutropenia (CIN) and Quality of Life (QoL):
Barry Fortner, PhD
Fatigue, Menopausal Symptoms and Cognitive Function in Women During and After Adjuvant Chemotherapy for Breast Cancer:
Ian Tannock, MD, PhD
All Patient Refined Diagnostic Related Group (APR-DRG) and Case Mix Index (CMI)In An Acute Palliative Medicine Unit:
Ruth Lagman, MD, MPH
Role of the Cyclooxygenase Pathway in Chemotherapy-induced Oral Mucositis: Rajesh Lalla, BDS, PhD
Parenteral Administration of CG53135-05 (FGF-20) Reduces Radiation-induced Gastrointestinal Syndrome In Vivo:
Valerie Gerlach
Palifermin Does Not Interfere With the Anti-tumor Activity of 5FU, Cetuximab or Bevacizumab in the HT29 Human Colon Carcinoma Xenograft Model:
Luis Borges, PhD
Grantors:
Amgen AG
Ortho Biotech & Janssen - Cilag
Roche Laboratories, Inc.
sanofi-aventis
Ark Therapeutics
BioLink Communications
Laclede, Inc. |
|
Amgen Inc.
Lance Armstrong Foundation
Merck AG
Savient Pharmaceuticals, Inc.
Serono SA
Helsinn Healthcare SA
provided funding for the MASCC Symposium Hotel Room Key Card.
Ortho Biotech & Jansen-Cilag
provided funding for the MASCC Symposium Tote Bag.
Merck AG
provided funding for the MASCC Symposium Name Badge Holder.
Helsinn Healthcare SA and Merck AG
provided funding for the MASCC Symposium Hotel Room Drops.
| Thanks to our MASCC Corporate Advisory Council Members | Amgen AG
Endo Pharmaceuticals
GlaxoSmithKline
Helsinn Heathcare SA
McNeil Consumer & Specialty Pharmaceuticals
MGI Pharma
There will be a call for 2008 and 2009 meetings.
The meeting was adjourned at 13:00.
Respectfully submitted,
J Herrstedt, Secretary/per CR
MASCC Study Group Chair Meeting Minutes
June 30, 2005
Present: Board Members, Executive Director, Cindy Rittenberg and Chairpersons from the following Study Groups: Antiemetics, Infection, Mucositis, Oral Care, Palliative Medicine, Patient/Professional Education, Pediatrics, Psychosocial, Quality of Life, and Rehabilitation.
Absent: Chairperson from Fatigue, Growth Factors, and Hemostasis Study Groups
Introductions
Cindy Rittenberg gave each person a “conflict of interest†form to sign and return to her.
Introduced Judi Johnson as the new MASCC staff person. One of her responsibilities will be coordination of study group activities. Contact her for any questions or activities/projects you wish to conduct (judibj@mn.rr.com).
Matti Aapro, MASCC President greeted everyone and shared his view on the important role of study groups within MASCC. He asked that each chairperson develop a core group of members within their study group. In the coming year he requested that each group:
(1) identify a project to be carried out by the group members. MASCC will provide up to $1,000 USD to any group who presents a proposal for a project that is within the mission and scope of MASCC. This project could be a survey, development of a clinical assessment tool, content development for the web site, etc.
(2) each study chair communicate with their group members on a regular basis through the email. Need to contact C. Rittenberg if you need an updated list of member’s email addresses.
(3) review abstracts for the next year’s meeting
(4) update their section on the MASCC web site. Provide an updated overview statement of approximately 100 words. Select presentations from this year’s meeting that should be listed on their study group’s site.
Discussion: E.Tierman of psychosocial group requested that study chairs be given the opportunity to develop topic/speakers for session at annual meeting. The tentative program topics will be emailed to each study chair. Responses are due back by July 24th.
A, Altman, chair of the pediatric group, expressed concern for developing a project that is unique to their group. Suggested that he look for links with other study groups. For example: the mucositis study group is working jointly with the education group on implementing the new mucositis guidelines.
Linda Elting, chair of the Outcomes and Healthcare Economics submitted a letter to the BOD (and accepted) recommending that this study group be closed for immediate future. Currently the only active/interested members have been the members who represent industry. She has indicated her willingness to be available to other study groups who want to design an economic piece of a project, to develop a research resource bank for the web, etc.
Submitted by: Judi Johnson PhD RN
MASCC Associate Director
| 
